BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

British Thoracic Society Standards of Care Committee, British Thoracic Society Standards of Care Committee

Abstract

Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor alpha (anti-TNF-alpha) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.

References

    1. Am J Health Syst Pharm. 2000 Feb 1;57(3):225-34
    1. AIDS. 1999 Mar 11;13(4):435-45
    1. N Engl J Med. 2001 Mar 22;344(12):907-16
    1. N Engl J Med. 2001 Oct 11;345(15):1098-104
    1. Ann Intern Med. 2002 Oct 15;137(8):640-7
    1. Int J Tuberc Lung Dis. 2002 Nov;6(11):995-1000
    1. Lancet Infect Dis. 2003 Mar;3(3):148-55
    1. Am J Respir Crit Care Med. 2003 Mar 15;167(6):824-7
    1. Arthritis Rheum. 2004 Feb;50(2):372-9
    1. Clin Gastroenterol Hepatol. 2004 Apr;2(4):309-13
    1. Am Rev Respir Dis. 1973 Apr;107(4):523-9
    1. Thorax. 1997 Dec;52(12):1060-7
    1. Inflamm Bowel Dis. 1998 Nov;4(4):328-9
    1. JAMA. 1999 Mar 17;281(11):1014-8
    1. Thorax. 2001 Mar;56(3):173-9

Source: PubMed

3
Abonnere